Catalyst Wire Dossier Catalyst Wire Dossier

FLAMOD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FLAMOD, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol [Phase 1]

See pricing